GSK boss Emma Walmsley bows out as HIV and cancer drugs supercharge sales

GSK lifted profit expectations for the year after the pharma group's sales were boosted by bumper demand for HIV and cancer drugs in the third quarter.

GSK boss Emma Walmsley bows out as HIV and cancer drugs supercharge sales
GSK lifted profit expectations for the year after the pharma group's sales were boosted by bumper demand for HIV and cancer drugs in the third quarter.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow